Testosterone Replacement and Resistance Exercise in HIV-Infected Men With Weight Loss and Low Testosterone Levels
Top Cited Papers
Open Access
- 9 February 2000
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 283 (6) , 763-770
- https://doi.org/10.1001/jama.283.6.763
Abstract
Weight loss during the course of human immunodeficiency virus (HIV) infection is associated with increased mortality and adverse disease outcome.1-4 Of the various therapies being considered for the treatment of HIV-associated weight loss, testosterone and exercise are attractive because they are relatively inexpensive and safe. There is a high prevalence of low testosterone levels in HIV-infected men.4-11 Serum testosterone levels are lower in those with weight loss9 and correlate with deficits in muscle mass,11 low Karnofsky scores,12 and disease progression.10,13 Replacement doses of testosterone augment lean body mass and muscle strength in healthy, hypogonadal men.14-16 These data have led to the hypothesis that testosterone replacement might also increase muscle mass and strength in HIV-infected men with low testosterone levels. Some of the studies17-29 that have examined the effects of androgen administration on weight and body composition in HIV-infected men were not placebo-controlled,23-27 and most failed to control energy intake and exercise stimulus.23-28 Two of the 4 placebo-controlled studies of testosterone supplementation of HIV-infected men17,18 reported gains in fat-free mass (FFM), while others19,20 found no change. None of the previous androgen studies in HIV-infected men has demonstrated improvements in muscle strength.17-20,23-28 The effects of resistance exercise alone and in combination with testosterone in HIV-infected men are unknown.Keywords
This publication has 36 references indexed in Scilit:
- The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infectionThe American Journal of Medicine, 1999
- Recombinant Human Growth Hormone in Patients with HIV-Associated WastingAnnals of Internal Medicine, 1996
- Recombinant Human Growth Hormone, Insulin-like Growth Factor 1, and Combination Therapy in AIDS-Associated WastingAnnals of Internal Medicine, 1996
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infectionAIDS, 1996
- Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infectionBritish Journal of Nutrition, 1996
- Health Related Quality of Life in HIV DiseaseAssessment, 1995
- Effect of Anabolic Steroids on HIV-Related Wasting MyopathySouthern Medical Journal, 1993
- Endocrine function in 98 HIV-infected patientsAIDS, 1991
- Endocrine disorders in men infected with human immunodeficiency virusThe American Journal of Medicine, 1988